Evidence map›Paper›PMID 37386247›Full record

ArticleNature genetics2023

Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci.

Xikun Han, Puya Gharahkhani, Andrew R Hamel, Jue Sheng Ong, Miguel E Rentería, Puja Mehta, Xianjun Dong, Francesca Pasutto, Christopher Hammond, Terri L Young and 21 more

Abstract read
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Neuroinflammation in glaucoma: a myriad of cellular pathways and players.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Xikun Han *Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. hanxikun2017@gmail.com.ORCID 0000-0002-3823-7308
Puya Gharahkhani *Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-4203-5952
Andrew R HamelDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-6420-9573
Jue Sheng OngStatistical Genetics Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-6062-710X
Miguel E RenteríaFaculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.ORCID 0000-0003-4626-7248
Puja MehtaDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-3205-1163
Xianjun DongGenomics and Bioinformatics Hub, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0002-8052-9320
Francesca PasuttoInstitute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität, Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-0026-5362
Christopher HammondTwin Research and Genetic Epidemiology, King's College London, London, UK.ORCID 0000-0002-3227-2620
Terri L YoungDepartment of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-6994-9941
Pirro HysiTwin Research and Genetic Epidemiology, King's College London, London, UK.ORCID 0000-0001-5752-2510
Andrew J LoteryUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.ORCID 0000-0001-5541-4305
Eric JorgensonRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.ORCID 0000-0002-5829-8191
Hélène ChoquetDivision of Research, Kaiser Permanente Northern California (KPNC), Oakland, CA, USA.ORCID 0000-0001-9839-8667
Michael HauserDepartment of Medicine, Duke University, Durham, NC, USA.
Jessica N Cooke BaileyDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID 0000-0002-4001-8702
Toru NakazawaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masato AkiyamaDepartment of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID 0000-0002-1879-5476
Yukihiro ShigaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Zachary L Fuller23andMe, Inc., Sunnyvale, CA, USA.
Xin Wang23andMe, Inc., Sunnyvale, CA, USA.ORCID 0000-0001-7242-357X
Alex W HewittMenzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.ORCID 0000-0002-5123-5999
Jamie E CraigDepartment of Ophthalmology, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia.
Louis R PasqualeDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-5835-3496
David A MackeyCentre for Ophthalmology and Visual Science, University of Western Australia, Lions Eye Institute, Perth, Western Australia, Australia.
Janey L WiggsDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1890-3278
Anthony P KhawajaNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.ORCID 0000-0001-6802-8585
Ayellet V SegrèDepartment of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
23andMe Research Team
International Glaucoma Genetics Consortium
Stuart MacGregorStatistical Genetics Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0001-6731-8142

Funding

P30 Core Grant for Vision ResearchP30EY014104 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Janey L Wiggs · 2002 to 2026
$15.1M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI AKIHIRO IKEDA · 2005 to 2026
$12.6M
Gene-Environment Interactions in GlaucomaR01EY015473 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI PASQUALE, LOUIS ROBERT · 2005 to 2021
$8.3M
The NEIGHBORHOOD: POAG Heritable Overall Operational DatabaseR01EY022305 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI WIGGS, JANEY L · 2012 to 2025
$7.9M
Uncovering novel biological processes and pathogenic mechanisms for glaucomaR01EY031424 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Ayellet Vered Segre · 2020 to 2026
$4.5M
Understanding the clinical impact of cumulative genetic risk to glaucomaR01EY032559 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Louis Robert Pasquale, Janey L Wiggs · 2021 to 2026
$4.3M
Prioritizing diversity in polygenic risk prediction of primary open-angle glaucomaR01EY033829 · NEI · EAST CAROLINA UNIVERSITY · PI Jessica N Cooke Bailey · 2022 to 2026
$3.6M
The Role of Refractive Error in the Etiology of GlaucomaR01EY027004 · NEI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHOQUET, HELENE · 2017 to 2020
$1.6M
Medical Research Council MR/T040912/1NEI NIH HHS P30 EY014104NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY015473NEI NIH HHS R01 EY022305NEI NIH HHS R01 EY027004NEI NIH HHS R01 EY031424NEI NIH HHS R01 EY032559NEI NIH HHS R01 EY033829
6 · The paper itself

Abstract

Glaucoma, a leading cause of irreversible blindness, is a highly heritable human disease. Previous genome-wide association studies have identified over 100 loci for the most common form, primary open-angle glaucoma. Two key glaucoma-associated traits also show high heritability: intraocular pressure and optic nerve head excavation damage quantified as the vertical cup-to-disc ratio. Here, since much of glaucoma heritability remains unexplained, we conducted a large-scale multitrait genome-wide association study in participants of European ancestry combining primary open-angle glaucoma and its two associated traits (total sample size over 600,000) to substantially improve genetic discovery power (263 loci). We further increased our power by then employing a multiancestry approach, which increased the number of independent risk loci to 312, with the vast majority replicating in a large independent cohort from 23andMe, Inc. (total sample size over 2.8 million; 296 loci replicated at P < 0.05, 240 after Bonferroni correction). Leveraging multiomics datasets, we identified many potential druggable genes, including neuro-protection targets likely to act via the optic nerve, a key advance for glaucoma because all existing drugs only target intraocular pressure. We further used Mendelian randomization and genetic correlation-based approaches to identify novel links to other complex traits, including immune-related diseases such as multiple sclerosis and systemic lupus erythematosus.

Indexed as

GlaucomaGlaucoma, Open-AngleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansIntraocular PressureOptic NervePolymorphism, Single Nucleotide

Identifiers

PMID37386247
PMCPMC10335935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.